1. Home
  2. MBX
  3. MBX News

Latest MBX BIOSCIENCES INC (MBX) News on December 27, 2024

MBX Biosciences to Participate in 43rd Annual J.P. Morgan Healthcare Conference
MBX

GlobeNewswire

8 days ago

MBX Biosciences to Participate in 43rd Annual J.P. Morgan Healthcare Conference

MBX Biosciences Announces MBX 2109 Phase 1 Study Results Published in The Journal of Clinical Endocrinology and Metabolism
MBX

GlobeNewswire

24 days ago

MBX Biosciences Announces MBX 2109 Phase 1 Study Results Published in The Journal of Clinical Endocrinology and Metabolism

MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia
MBX

GlobeNewswire

a month ago

MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia

MBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
MBX

GlobeNewswire

2 months ago

MBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update

MBX Biosciences to Participate in Upcoming November Investor Conferences
MBX

GlobeNewswire

2 months ago

MBX Biosciences to Participate in Upcoming November Investor Conferences

Opening Day: Another trio of biotech IPOs make Friday debut
MBX

TipRanks

2 months ago

Opening Day: Another trio of biotech IPOs make Friday debut

MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting
MBX

GlobeNewswire

3 months ago

MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting

MBX

GuruFocus.com

3 months ago

Deep Track Capital, LP's Strategic Acquisition in MBX Biosciences Inc

MBX

GuruFocus.com

3 months ago

OrbiMed Advisors LLC Acquires New Stake in MBX Biosciences Inc

MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
MBX

GlobeNewswire

3 months ago

MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Share on Social Networks: